Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Immune system functional pathway analysis using single cell network profiling (SCNP): a novel tool in cancer immunotherapy.

Cesano A, Spellmeyer D.

Methods Mol Biol. 2014;1102:583-99. doi: 10.1007/978-1-62703-727-3_31.

PMID:
24259000
2.

Single-cell network profiling of peripheral blood mononuclear cells from healthy donors reveals age- and race-associated differences in immune signaling pathway activation.

Longo DM, Louie B, Putta S, Evensen E, Ptacek J, Cordeiro J, Wang E, Pos Z, Hawtin RE, Marincola FM, Cesano A.

J Immunol. 2012 Feb 15;188(4):1717-25. doi: 10.4049/jimmunol.1102514. Epub 2012 Jan 13.

3.

Single cell network profiling assay in bladder cancer.

Covey TM, Vira MA, Westfall M, Gulrajani M, Cholankeril M, Okhunov Z, Levey HR, Marimpietri C, Hawtin R, Fields SZ, Cesano A.

Cytometry A. 2013 Apr;83(4):386-95. doi: 10.1002/cyto.a.22244. Epub 2013 Jan 8.

4.

Functional pathway analysis in acute myeloid leukemia using single cell network profiling assay: effect of specimen source (bone marrow or peripheral blood) on assay readouts.

Cesano A, Rosen DB, O'Meara P, Putta S, Gayko U, Spellmeyer DC, Cripe LD, Sun Z, Uno H, Litzow MR, Tallman MS, Paietta E.

Cytometry B Clin Cytom. 2012 May;82(3):158-72. doi: 10.1002/cyto.b.21007. Epub 2012 Feb 14.

5.

Single-cell network profiling (SCNP) by flow cytometry in autoimmune disease.

Covey TM, Cesano A, Parkinson DR.

Autoimmunity. 2010 Nov;43(7):550-9. doi: 10.3109/08916931003674774. Review.

PMID:
20482423
6.

Racial differences in B cell receptor signaling pathway activation.

Longo DM, Louie B, Mathi K, Pos Z, Wang E, Hawtin RE, Marincola FM, Cesano A.

J Transl Med. 2012 Jun 6;10:113. doi: 10.1186/1479-5876-10-113.

7.

Single cell network profiling (SCNP): mapping drug and target interactions.

Covey TM, Putta S, Cesano A.

Assay Drug Dev Technol. 2010 Jun;8(3):321-43. doi: 10.1089/adt.2009.0251.

PMID:
20158439
8.

High-dimensional analysis of the aging immune system: verification of age-associated differences in immune signaling responses in healthy donors.

Longo DM, Louie B, Ptacek J, Friedland G, Evensen E, Putta S, Atallah M, Spellmeyer D, Wang E, Pos Z, Marincola FM, Schaeffer A, Lukac S, Railkar R, Beals CR, Cesano A, Carayannopoulos LN, Hawtin RE.

J Transl Med. 2014 Jun 21;12:178. doi: 10.1186/1479-5876-12-178.

9.

Functional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP).

Rosen DB, Minden MD, Kornblau SM, Cohen A, Gayko U, Putta S, Woronicz J, Evensen E, Fantl WJ, Cesano A.

PLoS One. 2010 Oct 27;5(10):e13543. doi: 10.1371/journal.pone.0013543.

10.

Inter-donor variation in cell subset specific immune signaling responses in healthy individuals.

Longo DM, Louie B, Wang E, Pos Z, Marincola FM, Hawtin RE, Cesano A.

Am J Clin Exp Immunol. 2012 Apr 24;1(1):1-11. Print 2012.

11.

Applications of systems biology in cancer immunotherapy: from target discovery to biomarkers of clinical outcome.

Guhathakurta D, Sheikh NA, Meagher TC, Letarte S, Trager JB.

Expert Rev Clin Pharmacol. 2013 Jul;6(4):387-401. doi: 10.1586/17512433.2013.811814. Review.

PMID:
23927667
12.

High-dimensional single-cell cancer biology.

Irish JM, Doxie DB.

Curr Top Microbiol Immunol. 2014;377:1-21. doi: 10.1007/82_2014_367. Review.

13.
14.

Emerging applications of flow cytometry in solid tumor biology.

Chang Q, Hedley D.

Methods. 2012 Jul;57(3):359-67. doi: 10.1016/j.ymeth.2012.03.027. Epub 2012 Apr 6. Review.

PMID:
22503773
15.

Screening: CyTOF-the next generation of cell detection.

Cheung RK, Utz PJ.

Nat Rev Rheumatol. 2011 Jul 26;7(9):502-3. doi: 10.1038/nrrheum.2011.110. No abstract available. Erratum in: Nat Rev Rheumatol. 2012 Oct;8(10):562.

16.

Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.

Varker KA, Kondadasula SV, Go MR, Lesinski GB, Ghosh-Berkebile R, Lehman A, Monk JP, Olencki T, Kendra K, Carson WE 3rd.

Clin Cancer Res. 2006 Oct 1;12(19):5850-8.

17.

Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.

Khawli LA, Hu P, Epstein AL.

Handb Exp Pharmacol. 2008;(181):291-328. Review.

PMID:
18071951
18.

Tumor-associated antigens and biomarkers in cancer and immune therapy.

Malyankar UM.

Int Rev Immunol. 2007 May-Aug;26(3-4):223-47. Review.

PMID:
17558745
19.

Microarray analysis for a comprehensive immunological-status evaluation during cancer vaccine immune monitoring.

MonsurrĂ² V, Marincola FM.

J Biomed Biotechnol. 2011;2011:307297. doi: 10.1155/2011/307297. Epub 2011 Sep 29. Review.

20.

Genes to vaccines for immunotherapy: how the molecular biology revolution has influenced cancer immunology.

Laheru DA, Pardoll DM, Jaffee EM.

Mol Cancer Ther. 2005 Nov;4(11):1645-52. Review.

Supplemental Content

Support Center